UBS Group’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.17M | Sell |
227,348
-22,968
| -9% | -$724K | ﹤0.01% | 2738 |
|
|
2025
Q1 | $8.2M | Buy |
250,316
+50,290
| +25% | +$1.65M | ﹤0.01% | 2549 |
|
|
2024
Q4 | $7.23M | Buy |
200,026
+91,168
| +84% | +$3.3M | ﹤0.01% | 2643 |
|
|
2024
Q3 | $3.39M | Buy |
108,858
+28,772
| +36% | +$897K | ﹤0.01% | 2589 |
|
|
2024
Q2 | $2.14M | Buy |
80,086
+15,542
| +24% | +$416K | ﹤0.01% | 2799 |
|
|
2024
Q1 | $2.2M | Sell |
64,544
-875
| -1% | -$29.8K | ﹤0.01% | 2893 |
|
|
2023
Q4 | $1.89M | Buy |
65,419
+46,390
| +244% | +$1.34M | ﹤0.01% | 2898 |
|
|
2023
Q3 | $525K | Sell |
19,029
-34,884
| -65% | -$962K | ﹤0.01% | 3560 |
|
|
2023
Q2 | $1.62M | Buy |
53,913
+14,278
| +36% | +$429K | ﹤0.01% | 2862 |
|
|
2023
Q1 | $1.44M | Buy |
39,635
+11,573
| +41% | +$419K | ﹤0.01% | 2878 |
|
|
2022
Q4 | $1M | Buy |
28,062
+20,517
| +272% | +$732K | ﹤0.01% | 3139 |
|
|
2022
Q3 | $256K | Buy |
7,545
+5,961
| +376% | +$202K | ﹤0.01% | 3874 |
|
|
2022
Q2 | $45K | Sell |
1,584
-82,180
| -98% | -$2.33M | ﹤0.01% | 4991 |
|
|
2022
Q1 | $2.71M | Sell |
83,764
-15,235
| -15% | -$492K | ﹤0.01% | 2421 |
|
|
2021
Q4 | $2.89M | Buy |
98,999
+95,951
| +3,148% | +$2.8M | ﹤0.01% | 2582 |
|
|
2021
Q3 | $81K | Sell |
3,048
-21,095
| -87% | -$561K | ﹤0.01% | 4900 |
|
|
2021
Q2 | $744K | Sell |
24,143
-151,006
| -86% | -$4.65M | ﹤0.01% | 3467 |
|
|
2021
Q1 | $4.59M | Sell |
175,149
-6,233
| -3% | -$163K | ﹤0.01% | 2046 |
|
|
2020
Q4 | $4.56M | Buy |
181,382
+164,612
| +982% | +$4.14M | ﹤0.01% | 1920 |
|
|
2020
Q3 | $350K | Sell |
16,770
-12,947
| -44% | -$270K | ﹤0.01% | 3648 |
|
|
2020
Q2 | $706K | Sell |
29,717
-11,111
| -27% | -$264K | ﹤0.01% | 3115 |
|
|
2020
Q1 | $734K | Sell |
40,828
-12,747
| -24% | -$229K | ﹤0.01% | 2909 |
|
|
2019
Q4 | $1.27M | Buy |
53,575
+10,012
| +23% | +$238K | ﹤0.01% | 3133 |
|
|
2019
Q3 | $4.49M | Sell |
43,563
-652,699
| -94% | -$67.2M | ﹤0.01% | 1937 |
|
|
2019
Q2 | $23M | Buy |
696,262
+19,911
| +3% | +$659K | 0.01% | 906 |
|
|
2019
Q1 | $23.7M | Buy |
676,351
+325,468
| +93% | +$11.4M | 0.01% | 847 |
|
|
2018
Q4 | $11.7M | Buy |
350,883
+28,143
| +9% | +$935K | 0.01% | 1132 |
|
|
2018
Q3 | $16.3M | Buy |
322,740
+293,120
| +990% | +$14.8M | 0.01% | 1076 |
|
|
2018
Q2 | $1.77M | Buy |
29,620
+15,274
| +106% | +$914K | ﹤0.01% | 2628 |
|
|
2018
Q1 | $657K | Buy |
14,346
+641
| +5% | +$29.4K | ﹤0.01% | 3309 |
|
|
2017
Q4 | $546K | Sell |
13,705
-30,817
| -69% | -$1.23M | ﹤0.01% | 3407 |
|
|
2017
Q3 | $1.78M | Buy |
44,522
+29,740
| +201% | +$1.19M | ﹤0.01% | 2575 |
|
|
2017
Q2 | $637K | Sell |
14,782
-158
| -1% | -$6.81K | ﹤0.01% | 3200 |
|
|
2017
Q1 | $468K | Sell |
14,940
-5,071
| -25% | -$159K | ﹤0.01% | 3317 |
|
|
2016
Q4 | $505K | Sell |
20,011
-7,678
| -28% | -$194K | ﹤0.01% | 3308 |
|
|
2016
Q3 | $684K | Buy |
27,689
+23,175
| +513% | +$572K | ﹤0.01% | 2958 |
|
|
2016
Q2 | $92K | Buy |
4,514
+32
| +0.7% | +$652 | ﹤0.01% | 4263 |
|
|
2016
Q1 | $68K | Sell |
4,482
-47,448
| -91% | -$720K | ﹤0.01% | 4488 |
|
|
2015
Q4 | $698K | Buy |
51,930
+1,701
| +3% | +$22.9K | ﹤0.01% | 2925 |
|
|
2015
Q3 | $705K | Buy |
50,229
+3,212
| +7% | +$45.1K | ﹤0.01% | 2886 |
|
|
2015
Q2 | $798K | Buy |
47,017
+2,393
| +5% | +$40.6K | ﹤0.01% | 2947 |
|
|
2015
Q1 | $540K | Buy |
44,624
+12,283
| +38% | +$149K | ﹤0.01% | 3177 |
|
|
2014
Q4 | $269K | Buy |
+32,341
| New | +$269K | ﹤0.01% | 3576 |
|